January 27, 2021
Immunicum AB expanding its Netherlands R&D facilities in Leiden
Immunicum AB will move its in-house research and process development activities into a new facility at the Leiden Bio Science…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 27, 2021
Promising therapy for menstrual pain tested by Myovant Sciences, Pfizer
Myovant Sciences and Pfizer said Monday that the Phase 3 SPIRIT long-term extension study of the investigational once-daily relugolix combination…
January 15, 2021
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
LUXEMBOURG–(BUSINESS WIRE)–The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need…
December 22, 2020
Pfizer and BioNTech got positive opinion for their COVID-19 vaccine in EU
European Commission’s decision on conditional marketing authorization is expected imminently, after the positive CHMP opinion, which will make BNT162b2 if authorized, the first COVID-19 vaccine available in the European Union.
December 22, 2020
COVID-19: targeted treatment trial launched in Vienna
A phase II clinical trial of a treatment for COVID-19 patients is currently starting at the Medical University of Vienna as a sub-study of the Austrian CoronaVirus Adaptive Clinical Trial (ACOVACT), as an academia-industry collaboration (investigator Initiated trial) between Apogenix AG and its scientific consultant Henning Walczak and his teams at the University of Cologne and University College London (UCL).
December 21, 2020
Baris Erdogan takes over as CEO of Clinerion
Baris Erdogan, currently Vice President, Site & Patient Networks, at Clinerion, has been promoted by the Board of Directors to the position of Chief Executive Officer as of January 1st, 2021. After a three-year tenure, Clinerion’s current CEO, Ian Rentsch, has decided to step down for personal reasons and to return to his family in Berlin by the end of January, 2021.
December 18, 2020
European Commission Exercises Option for Additional 80 Million Doses of Moderna’s COVID-19 Vaccine Candidate
Total of 160 million doses ordered by the European Commission to date CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology…
December 10, 2020
Austria’s biotech companies establish association BIOTECH AUSTRIA
Today BIOTECH AUSTRIA, the first specific branch association for the biotechnology industry in Austria was founded. The founding members include numerous companies and institutions of Austrian biotechnology. The foundation of the association arises from an initiative by board members of APEIRON Biologics AG, Haplogen Bioscience GmbH, Hookipa Pharma GmbH and Lexogen GmbH.
December 9, 2020
HALIX inks deal with AstraZeneca for commercial manufacture of COVID-19 vaccine
HALIX B.V. has signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine.
December 8, 2020
SeraNovo names Michiel Van Speybroeck as head of development for clinical studies
SeraNovoa pharmaceutical company with a breakthrough proprietary formulation platform for enhancing drug bioavailability has appointed Dr Michiel Van Speybroeck to the role of Chief Development Officer (CDO) with immediate effect.